Morepen Labs Completes Phase 1 Expansion; API & CDMO Capacity Hits 614 KL
Morepen Laboratories reaches 614 KL reactor capacity following the completion of its Phase 1 expansion ahead of schedule, targeting API and CDMO growth.
ALFA News
Straight from the exchange filing
Morepen Laboratories reaches 614 KL reactor capacity following the completion of its Phase 1 expansion ahead of schedule, targeting API and CDMO growth.